Search results
Analysis-Pope's friends, observers try to make sense of homophobic PR disaster
Reuters via Yahoo News· 20 hours agoFrancis is a pope of many firsts: the first to use that name, the first from Latin America, the...
Lifesaving childbirth blood loss intervention is highly cost-effective, finds 78-hospital analysis
Medical Xpress· 19 hours agoA lifesaving package including early detection and bundled treatment for women who have heavy...
Analysis: This NBA Finals will show if the Celtics are ready for pressure - The Morning Sun
The Morning Sun· 23 hours agoJayson Tatum and Jaylen Brown said all the right things after the Boston Celtics fell in the NBA...
US weapons parts used in Israeli attack on Gaza school: Al Jazeera analysis
Al Jazeera· 11 hours agoAmong the rubble of the United Nations-run al-Sardi school in central Gaza’s Nuseirat refugee camp...
Analysis | Gov. Kathy Hochul’s odd argument against New York congestion pricing
Washington Post· 1 day agoThere were several reasons offered in support of the congestion pricing plan that was supposed to go...
Rising temps, CO2 levels raise significant climate change concerns
CBS News· 2 hours agoA series of new studies on climate change is making clear what scientists and researchers have long...
ANALYSIS: ATA’s Chris Spear earns $1.9M, but where are his results?
FreightWaves via Yahoo Finance· 1 day agoBased on its results this Congress, the American Trucking Associations’ lobbying efforts make it...
Is Mastercard Incorporated (MA) A Good Quality Stock to Buy Now?
Insider Monkey via Yahoo Finance· 23 minutes agoWe recently compiled the list of the 13 Best Quality Stocks To Buy according to the hedge funds...
Is Eli Lilly and Company (LLY) A Good “Quality Stock” to Buy Now?
Insider Monkey via Yahoo Finance· 18 minutes agoWe recently compiled the list of the 13 Best Quality Stocks To Buy according to the hedge funds...
FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug
KSL Salt Lake City· 23 hours agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...